What is the current opioid analgesics market size?

The opioid analgesics market size is approximately USD 11.6 billion as of 2022.

What is the expected growth forecast for the opioid analgesics market?

The market is expected to grow at a CAGR of 3.8% from 2023 to 2028.

What are the key drivers of the opioid analgesics market?

Increasing demand for pain management and rising prevalence of chronic diseases drive the market.

What are the major challenges facing the opioid analgesics market?

Stringent regulations and growing concerns about opioid addiction hinder market growth.

Which regions are the leaders in the opioid analgesics market?

North America and Europe are the leading regions due to high demand and awareness.

Who are the top companies in the opioid analgesics market?

Pfizer, Johnson & Johnson, and Merck & Co. are among the top players in the market.

What are the future opportunities in the opioid analgesics market?

Developing abuse-deterrent formulations and expanding into emerging markets offer future opportunities.

How does technology impact the opioid analgesics market?

Advances in drug delivery systems and digital health technologies improve treatment outcomes.

What is the regulatory landscape of the opioid analgesics market?

Regulatory bodies implement strict guidelines to ensure safe use and minimize addiction risks.

What is the future outlook of the opioid analgesics market?

The market is expected to experience steady growth due to increasing demand for pain management.

opioid analgesics Growth Opportunities & Strategic Forecast 2033

opioid analgesics by Application (Surgical Pain, Cancer Pain, Neuropathic Pain, Others), by Types (OxyContin, Vicodin, Morphine, Methadone, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $23.8 million

CAGR: 4.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $23.8 million

CAGR: 4.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

opioid analgesics Market Size | CAGR 4.2 Forecast 2033

opioid analgesics Growth Opportunities & Strategic Forecast 2033

🏭 Healthcare🌍 Global

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $23.8 million

CAGR: 4.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $23.8 million

CAGR: 4.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

opioid analgesics Market Overview

The opioid analgesics market refers to the industry involved in the development, production, and distribution of opioid-based pain relief medications. As a crucial segment of the pharmaceutical industry, the opioid analgesics market size is significant, with a growth outlook that is closely monitored by healthcare professionals and industry stakeholders. The current opioid analgesics market size is approximately $13.4 billion, with a projected market forecast indicating a compound annual growth rate (CAGR) of around 4.5% during the forecast period from 2026 to 2033. This industry expansion is driven by factors such as the increasing prevalence of chronic pain, advancements in technology shifts, and evolving consumer behavior. The scope of this market encompasses various types of opioid analgesics, including morphine, codeine, and fentanyl, among others.

Loading chart…

Key forces shaping the opioid analgesics market include regulations aimed at mitigating the risk of opioid addiction, competitive intensity among pharmaceutical companies, and supply-chain dynamics that impact the availability of these medications. The largest region for the opioid analgesics market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing healthcare expenditure and a growing patient population. As the market continues to evolve, industry stakeholders must navigate these complex factors to capitalize on emerging opportunities and address the pressing need for effective pain management solutions.

Report Overview

Report Attribute	Details
Market size value in 2025	23.80 million
Revenue forecast in 2033	33.08 million
Growth rate	CAGR of 4.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Pfizer Inc.; Abbott Laboratories; Johnson & Johnson; Novartis AG; Bayer AG; GlaxoSmithKline plc; F. Hoffmann-La Roche AG; Boehringer Ingelheim International GmbH; Bausch Health; Sanofi S.A.; Teva Pharmaceuticals; Purdue Pharmaceuticals L.P.; Endo International Plc; Assertio Holdings, Inc
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The opioid analgesics market is witnessing a significant transformation, driven by various factors that are shaping its growth forecast. The market dynamics are influenced by a complex interplay of drivers, restraints, opportunities, and challenges that are critical for stakeholders to understand.

Growth Drivers2 items

Increasing opioid analgesics market size due to the rising prevalence of chronic pain conditions, such as cancer, arthritis, and fibromyalgia, which is driving the demand for effective pain management solutions

Advancements in opioid analgesics market technology, including the development of novel formulations and delivery systems, such as abuse-deterrent and extended-release products, which are enhancing the efficacy and safety of opioid analgesics

Restraints2 items

Stringent regulations and guidelines governing the prescribing and use of opioid analgesics, which are limiting their adoption and contributing to a decline in opioid analgesics market size

Growing concerns about opioid misuse and addiction, which are leading to increased scrutiny of opioid analgesics and impacting their growth forecast

Opportunities2 items

Emerging opportunities in the opioid analgesics market for the development of alternative pain management therapies, such as non-opioid analgesics and device-based treatments, which can help reduce the burden of opioid-related harms

Increasing focus on personalized medicine and tailored treatment approaches, which can help optimize the use of opioid analgesics and improve patient outcomes, driving growth forecast in the opioid analgesics market

Challenges2 items

Complexities in balancing the benefits and risks of opioid analgesics, which requires careful consideration of factors such as efficacy, safety, and abuse potential, and can impact opioid analgesics market size

Need for interdisciplinary collaboration and coordination among healthcare stakeholders, including physicians, pharmacists, and patients, to ensure the safe and effective use of opioid analgesics and mitigate the risks associated with their use, affecting the growth forecast of the opioid analgesics market

Market Segmentation

Loading chart…

The Application segment of the opioid analgesics market is a crucial aspect of opioid analgesics segmentation. This segment is divided into various subtypes, including pain relief, cough suppression, and diarrhea suppression. The pain relief application holds the largest share in the opioid analgesics market, driven by the increasing prevalence of chronic pain and cancer pain. The cough suppression application is also significant, with opioids being used to treat dry, irritating coughs. Understanding the application segment is essential for market players to develop targeted strategies and products, ultimately contributing to the overall opioid analgesics market size.

The Types segment of the opioid analgesics market is another vital aspect of market taxonomy. This segment includes subtypes such as natural opioids, semi-synthetic opioids, and synthetic opioids. Natural opioids, such as morphine and codeine, are derived from opium and are widely used for pain relief. Semi-synthetic opioids, such as oxycodone and hydrocodone, are modified versions of natural opioids and offer improved efficacy and safety profiles. Synthetic opioids, such as fentanyl and methadone, are man-made and are often used for severe pain management. Analyzing the types segment helps market players to identify opportunities and challenges in the opioid analgesics market, enabling them to make informed decisions about product development and marketing strategies.

opioid analgesics Segmentation Breakdown11 items

Application

Surgical Pain

Cancer Pain

Neuropathic Pain

Others

Types

OxyContin

Vicodin

Morphine

Methadone

Others

Regional Insights

Loading chart…

The opioid analgesics market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of opioid analgesics, government investments in healthcare infrastructure, and a growing elderly population.

In North America, key drivers include established healthcare infrastructure, high awareness of opioid analgesics, and significant investments in research and development. Europe is driven by strict regulatory policies, growing demand for pain management, and collaborations between pharmaceutical companies. Asia Pacific is expected to experience rapid growth due to expanding healthcare coverage, increasing healthcare expenditure, and rising demand for opioid analgesics. Latin America and Middle East & Africa are anticipated to be driven by growing economies, improving healthcare infrastructure, and rising awareness of opioid analgesics.

The regional forecast indicates that the opioid analgesics market will experience significant growth in the coming years, with the Asia Pacific region expected to drive the market growth. The ecosystem maturity of the region, combined with favorable demographics and government support, is expected to contribute to the growth of the opioid analgesics market in the region.

Competitive Landscape

The opioid analgesics market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, and product innovation. The opioid analgesics competitive landscape is characterized by key competitive levers including regulatory approvals, certifications, and partnerships. Global players dominate the market, but local companies are also gaining traction, particularly in emerging economies.

Companies in the opioid analgesics market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, and R&D investments. Common differentiation strategies include technology, service model, and channel strength. However, companies face challenges such as margin pressure, compliance costs, and supply chain risks. To stay competitive, companies must adapt to changing market dynamics and regulatory requirements.

Pfizer Inc. focuses on innovation pipeline

Abbott Laboratories prioritizes regional expansion

Johnson & Johnson emphasizes vertical integration

Novartis AG pursues premium pricing

Bayer AG invests in local manufacturing

GlaxoSmithKline plc explores OEM tie-ups

Key opioid analgesics Companies14 items

Pfizer Inc.

Abbott Laboratories

Johnson & Johnson

Novartis AG

Bayer AG

GlaxoSmithKline plc

F. Hoffmann-La Roche AG

Boehringer Ingelheim International GmbH

Bausch Health

Sanofi S.A.

Teva Pharmaceuticals

Purdue Pharmaceuticals L.P.

Endo International Plc

Assertio Holdings, Inc

Market Ecosystem

The opioid analgesics ecosystem encompasses a complex network of participants, spanning from upstream raw material suppliers to downstream end users. The value chain analysis of this ecosystem reveals a multi-layered structure, comprising technology providers, integrators, channels, and end users. Value is created and captured at various stages, from the development of active pharmaceutical ingredients to the distribution and prescribing of opioid analgesics.

Raw material suppliers — providing active pharmaceutical ingredients

OEMs/manufacturers — producing opioid analgesics

Distributors/channel partners — delivering products to healthcare providers

Regulators/standards bodies — overseeing safety and efficacy

Service providers/after-sales — offering support and education

Data/analytics providers — tracking usage and outcomes

End users/buyers — healthcare providers and patients

The flow of value within the opioid analgesics ecosystem is influenced by various control points, including regulatory approvals, prescribing guidelines, and reimbursement policies. Dependency risks, such as input constraints and standards compliance, can impact the availability and quality of opioid analgesics. Switching costs, partnerships, and interoperability requirements can also affect the adoption and utilization of these products. The ecosystem's dynamics differ by region, with varying regulatory frameworks, healthcare systems, and patient needs shaping the value chain and influencing the flow of value.

Recent Industry Insights

The opioid analgesics industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between pharmaceutical companies and research institutions have focused on developing alternative pain management solutions, aiming to reduce the reliance on opioid-based treatments. Notable mergers and acquisitions have also taken place, with companies seeking to expand their product portfolios and strengthen their positions in the market. Furthermore, several product launches have introduced innovative, abuse-deterrent formulations, aligning with the regulatory push for safer opioid analgesics. These advancements underscore the evolving landscape of the opioid analgesics industry, driven by shifting consumer and enterprise trends, as well as funding rounds dedicated to research and development of new therapies.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the opioid analgesics market. The market attractiveness is moderate due to increasing regulatory pressures and growing competition. The competitive intensity is high, driven by the presence of several large pharmaceutical companies. The long-term outlook for the opioid analgesics market outlook is uncertain, with a need for innovative and safer treatment options. The innovation landscape is evolving, with a focus on developing alternative pain management therapies. The demand-supply balance is a key concern, with fluctuations in supply chains and changing demand patterns. Key risk factors include government regulations, public health concerns, and the potential for market disruption.

12 items

1. Executive Summary

2. opioid analgesics Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global opioid analgesics Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global opioid analgesics Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global opioid analgesics Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global opioid analgesics Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global opioid analgesics Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global opioid analgesics Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global opioid analgesics Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global opioid analgesics Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global opioid analgesics Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global opioid analgesics Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global opioid analgesics Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global opioid analgesics Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global opioid analgesics Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global opioid analgesics Market Competition by Key Manufacturers

9.1. Global opioid analgesics Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global opioid analgesics: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Pfizer Inc.

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Abbott Laboratories

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Johnson & Johnson

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Novartis AG

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Bayer AG

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. GlaxoSmithKline plc

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. F. Hoffmann-La Roche AG

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Boehringer Ingelheim International GmbH

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Bausch Health

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Sanofi S.A.

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Teva Pharmaceuticals

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Purdue Pharmaceuticals L.P.

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Endo International Plc

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Assertio Holdings, Inc

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global opioid analgesics Market

Figure 4: Global opioid analgesics Market: Drivers

Figure 5: Global opioid analgesics Market: Challenges

Figure 6: Global opioid analgesics Market: Trends

Figure 7: Global opioid analgesics Market: Opportunity

Figure 8: Global opioid analgesics Market: Restraint

Figure 9: Global opioid analgesics Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global opioid analgesics Market Value (USD Million) By Region

Figure 19: Global opioid analgesics Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global opioid analgesics Market Value (USD Million) By Region

Figure 27: Global opioid analgesics Market Share (%) By: Regions (2032)

Figure 28: Global opioid analgesics Market Volume (K) By Region

Figure 29: Global opioid analgesics Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global opioid analgesics Market Value (USD Million) By Region

Figure 37: Global opioid analgesics Market Share (%) By: Regions (2032)

Figure 38: Global opioid analgesics Market Volume (K) By Region

Figure 39: Global opioid analgesics Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

123 items

Table 1: Market Segmentation Analysis

Table 2: Global opioid analgesics Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global opioid analgesics Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global opioid analgesics Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global opioid analgesics Market Value (USD Million) By Region

Table 14: Global opioid analgesics Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global opioid analgesics Market Volume (K) By Region

Table 31: Global opioid analgesics Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global opioid analgesics Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global opioid analgesics Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global opioid analgesics Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Pfizer Inc. Basic Information And Sales Area

Table 52: Pfizer Inc.. Products Portfolio

Table 53: Abbott Laboratories Basic Information And Sales Area

Table 54: Abbott Laboratories. Products Portfolio

Table 55: Johnson & Johnson Basic Information And Sales Area

Table 56: Johnson & Johnson. Products Portfolio

Table 57: Novartis AG Basic Information And Sales Area

Table 58: Novartis AG. Products Portfolio

Table 59: Bayer AG Basic Information And Sales Area

Table 60: Bayer AG. Products Portfolio

Table 61: GlaxoSmithKline plc Basic Information And Sales Area

Table 62: GlaxoSmithKline plc. Products Portfolio

Table 63: F. Hoffmann-La Roche AG Basic Information And Sales Area

Table 64: F. Hoffmann-La Roche AG. Products Portfolio

Table 65: Boehringer Ingelheim International GmbH Basic Information And Sales Area

Table 66: Boehringer Ingelheim International GmbH. Products Portfolio

Table 67: Bausch Health Basic Information And Sales Area

Table 68: Bausch Health. Products Portfolio

Table 69: Sanofi S.A. Basic Information And Sales Area

Table 70: Sanofi S.A.. Products Portfolio

Table 71: Teva Pharmaceuticals Basic Information And Sales Area

Table 72: Teva Pharmaceuticals. Products Portfolio

Table 73: Purdue Pharmaceuticals L.P. Basic Information And Sales Area

Table 74: Purdue Pharmaceuticals L.P.. Products Portfolio

Table 75: Endo International Plc Basic Information And Sales Area

Table 76: Endo International Plc. Products Portfolio

Table 77: Assertio Holdings, Inc Basic Information And Sales Area

Table 78: Assertio Holdings, Inc. Products Portfolio

Table 79: Global Market Value (USD Million) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Value (USD Million) (2025-2032) By Types

Table 82: Global Market Share (%) By Types (2032)

Table 83: Global Market Volume (K) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Volume (K) (2025-2032) By Types

Table 86: Global Market Share (%) By Types (2032)

Table 87: Global opioid analgesics Market Value (USD Million) By Region

Table 88: Global opioid analgesics Market Share (%) By Region (2025-2032)

Table 89: North America Market Value (USD Million) (2025-2032) By Country

Table 90: North America Market Value (USD Million) (2025-2032) By Application

Table 91: North America Market Value (USD Million) (2025-2032) By Types

Table 92: Europe Market Value (USD Million) (2025-2032) By Country

Table 93: Europe Market Value (USD Million) (2025-2032) By Application

Table 94: Europe Market Value (USD Million) (2025-2032) By Types

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 96: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 98: South America Market Value (USD Million) (2025-2032) By Country

Table 99: South America Market Value (USD Million) (2025-2032) By Application

Table 100: South America Market Value (USD Million) (2025-2032) By Types

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 102: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 104: Global opioid analgesics Market Volume (K) By Region

Table 105: Global opioid analgesics Market Share (%) By Region (2025-2032)

Table 106: North America Market Volume (K) (2025-2032) By Country

Table 107: North America Market Volume (K) (2025-2032) By Application

Table 108: North America Market Volume (K) (2025-2032) By Types

Table 109: Europe Market Volume (K) (2025-2032) By Country

Table 110: Europe Market Volume (K) (2025-2032) By Application

Table 111: Europe Market Volume (K) (2025-2032) By Types

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 113: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 115: South America Market Volume (K) (2025-2032) By Country

Table 116: South America Market Volume (K) (2025-2032) By Application

Table 117: South America Market Volume (K) (2025-2032) By Types

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 119: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 121: Research Programs/Design For This Report

Table 122: Key Data Information From Secondary Sources

Table 123: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

opioid analgesics Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	23.80 million
Revenue forecast in 2033	33.08 million
Growth rate	CAGR of 4.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Pfizer Inc.; Abbott Laboratories; Johnson & Johnson; Novartis AG; Bayer AG; GlaxoSmithKline plc; F. Hoffmann-La Roche AG; Boehringer Ingelheim International GmbH; Bausch Health; Sanofi S.A.; Teva Pharmaceuticals; Purdue Pharmaceuticals L.P.; Endo International Plc; Assertio Holdings, Inc
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options